Evidence map›Paper›PMID 39911731›Full record

ReviewNanoscale advances2025

Structure-activity relationships in the development of single atom catalysts for sustainable organic transformations.

Deepshikha Roy, Kalyanjyoti Deori

Abstract readReview
In one paragraph

Review in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Deepshikha RoyKD's NAME (NanoMat&Energy) Lab, Department of Chemistry, Dibrugarh University Dibrugarh 786004 India kalchemdu@gmail.com kalchemdu@dibru.ac.in.
Kalyanjyoti DeoriKD's NAME (NanoMat&Energy) Lab, Department of Chemistry, Dibrugarh University Dibrugarh 786004 India kalchemdu@gmail.com kalchemdu@dibru.ac.in.ORCID https://orcid.org/0000-0003-0411-8324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single atom catalysts (SACs), which can provide the combined benefits of homogeneous and heterogeneous catalysts, are a revolutionary concept in the field of material research. The highly exposed catalytic surfaces, unsaturated sites, as well as unique structural and electronic properties of SACs have the potential to catalyze numerous reactions with unmatched efficiency and durability when stabilized on a suitable support. In this review, we have provided an intuitive insight into the strategies adopted in the last 5 years for morphology control of SACs to know about its impact on metal-support interaction and various organic transformations with special reference to metal oxides, alloys, metal-organic frameworks (MOFs) and carbon-based supports. This review also includes a brief description of unparalleled potentials of SACs and the recent advances in the catalysis of industrially important organic transformations, with special emphasis on the C-C cross-coupling reaction, biomass conversion, hydrogenation, oxidation and click chemistry. This unprecedented and unique perspective will highlight the interactions occurring within SACs that are responsible for their high catalytic efficiency, which will potentially benefit various organic transformations. We have also suggested plausible synergy of various other concepts such as defect engineering and piezocatalysis with SACs, which can provide a new direction to sustainable chemistry. A good understanding of the different types of metal-support interactions will help researchers develop morphology-controlled SACs with tunable properties and establish mechanisms for their exceptional catalytic behaviour in industrially important organic transformations.

Identifiers

PMID39911731
PMCPMC11792631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.